RRAS2 and astrocytoma (excluding glioblastoma): Our findings demonstrate that R-RAS2 mRNA and protein is overexpressed in a wide variety of human CNS tumors, including glioblastomas, astrocytomas, oligodendrogliomas and medulloblastomas.